温经逐瘀汤联合醋酸戈舍瑞林治疗子宫腺肌症的疗效及对血清NRP1、IGF-1的影响
吕孝丽 , 李潇 , 周月希 , 李瑞丽
中国医科大学学报 ›› 2026, Vol. 55 ›› Issue (7) : 577 -581.
温经逐瘀汤联合醋酸戈舍瑞林治疗子宫腺肌症的疗效及对血清NRP1、IGF-1的影响
Efficacy of Wenjing Zhuyu decoction combined with goserelin acetate in the treatment of adenomyosis and its impact on serum NRP1 and IGF-1 levels
目的 探讨温经逐瘀汤联合醋酸戈舍瑞林治疗子宫腺肌症的疗效及对血清神经纤毛蛋白-1 (NRP1)、胰岛素样生长因子-1 (IGF-1) 的影响。方法 选取2023年3月至2025年3月间河南省中医院收治的子宫腺肌症患者92例为研究对象,随机分为研究组和对照组,每组46例。对照组接受标准化醋酸戈舍瑞林治疗方案,研究组在对照组治疗基础上联合使用温经逐瘀汤治疗。比较2组中医证候评分、临床疗效、疼痛程度[视觉模拟评分法 (VAS)、疼痛强度量表 (PPI) ]、子宫状况[子宫体积、子宫内膜厚度、子宫动脉阻力指数、血管指数]、血清NRP1和IGF-1水平、不良反应发生情况。结果 治疗后,研究组证候评分、VAS评分、PPI评分、子宫体积、子宫内膜厚度、子宫动脉阻力指数及血清NRP1、IGF-1水平均较治疗前及对照组显著降低 (P < 0.05),血管指数较治疗前及对照组显著增加 (P < 0.05); 研究组总有效率显著高于对照组 (93.48% vs. 78.26%,P < 0.05); 2组不良反应率无统计学差异 (19.57% vs. 28.26%,P > 0.05) 结论 温经逐瘀汤联合醋酸戈舍瑞林治疗子宫腺肌症可显著改善患者临床症状,降低血清NRP1和IGF-1水平,且安全性良好。
Objective To investigate the efficacy of Wenjing Zhuyu decoction combined with goserelin acetate in the treatment of adenomyosis and its effects on the serum levels of neuropilin-1 (NRP1) and insulin-like growth factor-1 (IGF-1). Methods For this study,we enrolled 92 patients with adenomyosis admitted to the Henan Province Hospital of Traditional Chinese Medicine (between March 2023 and March 2025). The participants were randomly assigned to two groups (n = 46). The control group received standardized goserelin acetate treatment,whereas the study group received additional Wenjing Zhuyu decoction therapy. Comparisons were made between the two groups in terms of traditional Chinese medicine syndrome scores,clinical efficacy,pain severity (Visual Analog Scale [VAS] and Present Pain Intensity [PPI] scale),uterine conditions (uterine volume,endometrial thickness,uterine artery resistance index,and vascular index),serum NRP1 and IGF-1 levels,and the incidence of adverse reactions. Results After treatment,the study group showed significant reductions in traditional Chinese medicine syndrome,VAS,PPI and scores; uterine volume; endometrial thickness; uterine artery resistance index; and serum NRP1 and IGF-1 levels when compared with the baseline and control groups (P < 0.05),whereas the vascular index was significantly increased (P < 0.05). The total efficacy rate was significantly higher in the study group than in the control group (93.48% vs.78.26%,P < 0.05). No significant differences were observed in the overall incidence of adverse reactions between the two groups (19.57% vs. 28.26%,P > 0.05). Conclusion Wenjing Zhuyu decoction combined with goserelin acetate significantly improved the clinical symptoms,reduced serum NRP1 and IGF-1 levels,and demonstrated good safety for the treatment of adenomyosis,making it worthy of clinical promotion.
| [1] |
MOLDASSARINA RS. Modern view on the diagnostics and treatment of adenomyosis [J]. Arch Gynecol Obstet,2023,308 (1):171-181. DOI:10.1007/s00404-023-06982-1. |
| [2] |
程国珍,王东阁. 基于PSM法分析GnRHa联合地诺孕素治疗子宫腺肌症的疗效及对复发的影响 [J]. 中国性科学,2024,33 (12):58-62. DOI:10.3969/j.issn.1672-1993.2024.12.014. |
| [3] |
毛婷婷,蒋琼,王燕, |
| [4] |
郑筱萸. 中药新药临床研究指导原则:试行[M]. 北京:中国医药科技出版社,2002. |
| [5] |
刘叶倩,李弘,龚姗, |
| [6] |
|
| [7] |
|
| [8] |
凌爱华,赵维英. 温经活血汤联合艾灸对子宫腺肌病患者子宫体积与动脉血流的影响 [J]. 中国老年学杂志,2021,41 (2):301-304. DOI:10.3969/j.issn.1005-9202.2021.02.023. |
| [9] |
奚嘉. 奚嘉效方治验:助孕益膜汤 [J]. 江苏中医药,2022,54 (8):5-6. DOI:10.19844/j.cnki.1672-397X.2022.08.003. |
| [10] |
马静文,韩淑霞,杨志娟. 醋酸甲羟孕酮与地诺孕素治疗子宫内膜异位症患者的临床对比研究 [J]. 中国临床药理学杂志,2025, 41 (4):462-466. DOI:10.13699/j.cnki.1001-6821.2025.04.003. |
| [11] |
|
| [12] |
许力挺. 温经逐瘀汤联合温针灸对子宫腺肌症患者卵巢功能及MMP-9、VEGF水平的影响 [J]. 光明中医,2021,36 (2):240-243. DOI:10.3969/j.issn.1003-8914.2021.02.030. |
| [13] |
|
| [14] |
费婷婷,徐鸣,俞剑娣, |
国家自然科学基金(82205170)
河南省科技发展计划(232102310478)
河南省中医院 (河南中医药大学第二附属医院) 博士科研基金(2022BSJJ05)
/
| 〈 |
|
〉 |